96 related articles for article (PubMed ID: 10741556)
1. Membrane-permeant, bioactivatable analogues of cGMP as inducers of cell death in IPC-81 leukemia cells.
Schwede F; Brustugun OT; Zorn-Kruppa M; Døskeland SO; Jastorff B
Bioorg Med Chem Lett; 2000 Mar; 10(6):571-3. PubMed ID: 10741556
[TBL] [Abstract][Full Text] [Related]
2. New dimeric cGMP analogues reduce proliferation in three colon cancer cell lines.
Hoffmann D; Rentsch A; Vighi E; Bertolotti E; Comitato A; Schwede F; Genieser HG; Marigo V
Eur J Med Chem; 2017 Dec; 141():61-72. PubMed ID: 29028532
[TBL] [Abstract][Full Text] [Related]
3. Treatment of acute myelocytic leukemia with interleukin-6 Pseudomonas exotoxin fusion protein in a rat leukemia model.
Rozemuller H; Rombouts WJ; Touw IP; FitzGerald DJ; Kreitman RJ; Pastan I; Hagenbeek A; Martens AC
Leukemia; 1996 Nov; 10(11):1796-803. PubMed ID: 8892684
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of glucose transport by cyclic GMP in cardiomyocytes.
Bergemann C; Löken C; Becker C; Graf B; Hamidizadeh M; Fischer Y
Life Sci; 2001 Aug; 69(12):1391-406. PubMed ID: 11531163
[TBL] [Abstract][Full Text] [Related]
5. Chromophore-modified antineoplastic imidazoacridinones. Synthesis and activity against murine leukemias.
Cholody WM; Martelli S; Konopa J
J Med Chem; 1992 Jan; 35(2):378-82. PubMed ID: 1732555
[TBL] [Abstract][Full Text] [Related]
6. Cyclic GMP inhibits a pharmacologically distinct Na+/H+ exchanger variant in cultured rat astrocytes via an extracellular site of action.
Touyz RM; Picard S; Schiffrin EL; Deschepper CF
J Neurochem; 1997 Apr; 68(4):1451-61. PubMed ID: 9084415
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression.
Suhasini M; Boss GR; Pascual FE; Pilz RB
Cell Growth Differ; 1995 Dec; 6(12):1559-66. PubMed ID: 9019161
[TBL] [Abstract][Full Text] [Related]
8. Bioactivatable, membrane-permeant analogs of cyclic nucleotides as biological tools for growth control of C6 glioma cells.
Bartsch M; Zorn-Kruppa M; Kühl N; Genieser HG; Schwede F; Jastorff B
Biol Chem; 2003 Sep; 384(9):1321-6. PubMed ID: 14515995
[TBL] [Abstract][Full Text] [Related]
9. Caged compounds of hydrolysis-resistant analogues of cAMP and cGMP: synthesis and application to cyclic nucleotide-gated channels.
Hagen V; Dzeja C; Frings S; Bendig J; Krause E; Kaupp UB
Biochemistry; 1996 Jun; 35(24):7762-71. PubMed ID: 8672476
[TBL] [Abstract][Full Text] [Related]
10. Acetoxymethyl esters of phosphates, enhancement of the permeability and potency of cAMP.
Schultz C; Vajanaphanich M; Harootunian AT; Sammak PJ; Barrett KE; Tsien RY
J Biol Chem; 1993 Mar; 268(9):6316-22. PubMed ID: 8384207
[TBL] [Abstract][Full Text] [Related]
11. A calcium-permeable cGMP-activated cation conductance in hippocampal neurons.
Leinders-Zufall T; Rosenboom H; Barnstable CJ; Shepherd GM; Zufall F
Neuroreport; 1995 Sep; 6(13):1761-5. PubMed ID: 8541476
[TBL] [Abstract][Full Text] [Related]
12. Cyclic nucleotide-induced migration of electropermeabilized neutrophils: the effect of phosphodiesterase-resistant analogues.
VanUffelen BE; de Koster BM; VanSteveninck J; Elferink JG
Inflamm Res; 1997 Oct; 46(10):427-9. PubMed ID: 9372318
[TBL] [Abstract][Full Text] [Related]
13. The NO-cGMP-PKG pathway plays an essential role in the acquisition of ethanol resistance by cerebellar granule neurons.
Bonthius DJ; Karacay B; Dai D; Hutton A; Pantazis NJ
Neurotoxicol Teratol; 2004; 26(1):47-57. PubMed ID: 15001213
[TBL] [Abstract][Full Text] [Related]
14. Novel N7- and N1-substituted cGMP derivatives are potent activators of cyclic nucleotide-gated channels.
Strassmaier T; Karpen JW
J Med Chem; 2007 Aug; 50(17):4186-94. PubMed ID: 17665892
[TBL] [Abstract][Full Text] [Related]
15. Sustained elevation of cyclic guanosine monophosphate induces apoptosis in microglia.
Nimmervoll B; Svoboda N; Sacha B; Kerschbaum HH
Brain Res Bull; 2009 Dec; 80(6):428-32. PubMed ID: 19682559
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological activity of some 8-substituted selenoguanosine cyclic 3',5'-phosphates and related compounds.
Chu SH; Shiue CY; Chu MY
J Med Chem; 1975 Jun; 18(6):559-64. PubMed ID: 168384
[TBL] [Abstract][Full Text] [Related]
17. Atrial natriuretic peptide regulation of endothelial permeability is mediated by cGMP.
Lofton CE; Newman WH; Currie MG
Biochem Biophys Res Commun; 1990 Oct; 172(2):793-9. PubMed ID: 2173580
[TBL] [Abstract][Full Text] [Related]
18. Role of nitric oxide and cyclic guanosine 3',5'-monophosphate in the estrogen regulation of cervical epithelial permeability.
Gorodeski GI
Endocrinology; 2000 May; 141(5):1658-66. PubMed ID: 10803574
[TBL] [Abstract][Full Text] [Related]
19. Effects of cGMP-dependent phosphorylation on rat and human connexin43 gap junction channels.
Kwak BR; Sáez JC; Wilders R; Chanson M; Fishman GI; Hertzberg EL; Spray DC; Jongsma HJ
Pflugers Arch; 1995 Sep; 430(5):770-8. PubMed ID: 7478932
[TBL] [Abstract][Full Text] [Related]
20. Cyclic GMP-dependent pathways protect differentiated oligodendrocytes from multiple types of injury.
Benjamins JA; Nedelkoska L
Neurochem Res; 2007 Feb; 32(2):321-9. PubMed ID: 17191140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
